April 12, 2018 6:11pm

After positive momentum and lessened negative sentiment with the value battle trumped by momentum defining today’s upside

As geopolitical issues appeared to fade

 

However, I’m still waiting for downside bugles to trumpet change

 

Pre-open indication results:  4 HITs and 2 MISS

Research note: (ONVO +$0.04) - HIT

 

End of day briefing; the “numbers” speak!

Henry’omics:

Today’s moves … I write about market timing in “our” universe; specifically about  taking short-term profit which is why we have invested and solidifying our portfolios.

For those who have invested in the sector and stayed … after all the volatility of the advance/decline lines; we have been harmed by most (versus many) session’s action since 1/2/18.

The greatest move is timing the sell in the upside of the most having experienced the lows. So, the key for investors is staying in the sector understanding … SELLING into STRENGTH so one can come back after (always looming) pricing depressions.

It’s always a question of advantage before the FALL!

 

The advance/decline line scenario of 40 covered companies:   

  • The open was neutral with the A/DL to 18/18 and 4 flat;
  • The mid-day was positive with an A/DL of 25/11 and 4 flat;
  • The close concluded positive with an A/DL of 30/8 and 2 flat;

 

From the pre-open’s newsletter, “reap the harvest of the upside, sell into strength or buy into capricious strength? What’s a “bad hand” today? If you know which hands is always a fold 'em, you can have an upper hand and perhaps not bet the pot and lose.”

As I had stated, “I can’t see “the whites of their eyes” to push a BUY or SELL button; I have been right so far this week; patience is a virtue so I will wait to see the open and the 11:30 a.m. numbers”.

How many times have I mentioned he S&P 500 index (SPX) was most recently up 1.2% at 2,673, with a break above 2,673.61, its closing value for 2017, pushing the broad-market gauge into positive territory and representing its highest level since about three weeks?

We needed this S&P upside swing …

 

Review the 9 sessions of March’s close (of 40 covered companies):

  • Thursday closed POSITIVE with 8 decliners, 30 advancers and 2 flats;
  • Wednesday closed NEUTRAL with 19 decliners, 19 advancers and 2 flats;
  • Tuesday closed POSITIVE with 7 decliners, 32 advancers and 1 flats;
  • Monday closed POSITIVE with 12 decliners, 23 advancers and 5 flats;
  • Friday closed NEGATIVE with 32 decliners, 7 advancers and 1 flats;
  • Thursday closed NEGATIVE with 25 decliners, 11 advancers and 4 flats;
  • Wednesday closed POSITIVE with 11 decliners, 28 advancers and 1 flat;
  • Last Tuesday closed POSITIVE with 19 decliners, 19 advancers and 2 flats;
  • The previous Monday closed NEGATIVE with 9 decliners, 31 advancers and 0 flats

 

Pre-open indications: 4 HITs and 2 MISS

Biostage (BSTG) closed flat – hit;

  • Cellectis (CLLS) closed up +$0.17 – hit;
  • Fate Therapeutics (FATE) closed down -$0.02 – hit;
  • Regenxbio (RGNX) closed down -$0.20 – hit;
  • uniQuire (QURE) closed up +$0.30 – miss;
  • Vericel (VCEL) closed down -$0.32 – miss;

 

MY working five (5) trend lines:

… The greatest volume to the downside:  VCEL, MDXG, FATE, RGNX and STML

… Upside volume was weighted to:  BLCM, IMUC, VSTM, SGMO and XON

… Biggest $ downside:  RENE.L (-$4.50), VCEL (-$0.32), STML (-$0.20), RGNX (-$0.20) and AST (-$0.05)

… Best moves to the $ upside:  BLUE (+$3.35), ONCE (+$2.57), BLCM (+$1.39), XON (+$0.81) and AGTC (+$0.60)

… Flats: BSTG and PSTI

 

Daily analytics:

Stocks rose sharply on Thursday after President Donald Trump clarified his position on a possible missile attack in Syria, while bank shares popped ahead of earnings.

  • The Dow gained 293.60 points to close at 24,483.05.
  • The S&P 500 rose 0.8% to 2,663.99.
  • The NASDAQ advanced 1% to 7,140.25.

 

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market,

  • Thursday traded at 18.49 , down -8.65 %
  • Wednesday traded at 20.24, down -1.12% …
  • Tuesday traded at 20.47, down -5.97%
  • Monday traded at 21.98, up +2.28%
  • Friday traded at 21.49, up +13.46%
  • Last Thursday traded at 18.24 , down -5.58%

 

The iShares Russell 2000 (IWM) indicated:

  • Thursday was up +0.67%
  • Wednesday was up +0.22%
  • Tuesday +1.86%
  • Monday +0.12%
  • Friday -2%
  • Last Thursday +0.81%

 

The iShares NASDAQ Biotechnology (IBB) indicated:

  • Thursday was up +1.32%
  • Wednesday -0.35%
  • Tuesday +2.75%
  • Monday +1.82%
  • Friday -3.01%
  • Last Thursday -1.62%

 

The count - decliners versus gainers:

……. look at the differences in decliners:

  • Thursday’s decliners ranged from -0.14% <MDXG -$0.01 > to -5.49% <RENE.L -$4.50 > in 8 equities;
  • Wednesday’s decliners ranged from -0.01% <ONCE -$0.01 > to -6.42% <RGNX -$2.40 > in 19 equities;
  • Tuesday’s decliners ranged from -0.38% <BSTG -$0.01 > to -6.67% < AST -$0.10> in 7 equities;
  • Monday’s decliners ranged from -0.02% <FCSC -$0.00 > to -12.65% <KOOL -$0.21 > in 12 equities;
  • Friday’s decliners ranged from -0.50% <IMUC -$0.0012 > to -9.68% <AST -$0.15 > in 32 equities;
  • Last Thursday’s decliners ranged from -0.73% <CAPR -$0.01 > to -12.39% <CLLS -$4.10 > in 25 equities;

Versus

… Look at the percentage’s (%) and spreads …

  • Thursday’s gainers ranged from +0.30% <BCLI +$0.01 > to +20.29% <BLCM +$1.39 > in 30 equities;
  • Wednesday’s gainers ranged from +0.26% <IMUC +$0.001 > to +13.82% <FATE +$1.39 > in 19 equities;
  • Tuesday’s gainers ranged from +0.62% <BCLI +$0.02 > to +18.92% <RGNX +$5.95> in 32 equities;
  • Monday’s gainers ranged from +0.78% <BLCM +$0.05 > to +16.44% <QURE +$3.61 > in 23 equities;
  • Friday’s gainers ranged from +0.61% <OSIR +$0.05 > to +4.06% <BLFS +$0.08 > in 7 equities;
  • Last Thursday’s gainers ranged from +0.52% <ATHX +$0.01 > to +6.08% < BCLI +$0.20> in 11 equities;

                                                                                                                                                                               

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.